MERZ AESTHETICS PRESENTS NEW DATA HIGHLIGHTING PRODUCT SAFETY AND EFFICACY AT THE IMCAS WORLD CONGRESS 2023
MERZ AESTHETICS RECOGNIZES WINNERS OF THE 2022 MEDICAL AFFAIRS INNOVATION FORUM AT THE MERZ AESTHETICS EXPERT SUMMIT (MEXS)
MERZ AESTHETICS IS GETTING A NEW LOOK
Announcing 2 Million Ultherapy Treatments Worldwide
Merz Aesthetics to showcase new data at the 20th Aesthetics & Anti-Aging Medicine World Congress 2022
MERZ AESTHETICS BRINGS CONFIDENCE TO LIFE
MERZ AESTHETICS LAUNCHES SECOND ANNUAL INNOVATION FORUM
Merz Aesthetics to showcase new data at 19th Aesthetics & Anti-Aging Medicine World Congress 2021
Merz Aesthetics today confirmed its commitment as a global leader in medical aesthetics at the 19th Aesthetic & Anti-Aging Medicine World Congress (AMWC), with the presentation of data from its medical aesthetics portfolio and a clear focus on addressing the aesthetic needs of a diverse society.
MERZ AESTHETICS LAUNCHES INNOVATIVE MULTIMEDIA FORUM FOR HEALTH CARE PROFESSIONALS WORLDWIDE TO LEARN VIRTUALLY
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of the Merz Aesthetics Medical Forum, a unique online medical aesthetics education platform for health care professionals around the world.
MERZ AESTHETICS TO PRESENT DATA FROM MEDICAL AESTHETICS PORTFOLIO AT “THE AESTHETIC MEETING 2021” IN MIAMI
Merz Aesthetics announced the presentation of data from its extensive medical aesthetics portfolio at The Aesthetic Meeting 2021.
MERZ AESTHETICS AND CANDELA CORPORATION LAUNCH COMMERCIAL COLLABORATION CREATING BROAD MEDICAL AESTHETICS PORTFOLIO
Committed to innovative customer solutions and meeting patient demand for full-spectrum of medical aesthetic treatment.
Merz Aesthetics to sponsor and participate in first fully virtual medical aesthetics congress AMWC Global 2020
Merz Aesthetics, a global leader in medical aesthetics, today announced the presentation of data from its medical aesthetics portfolio at the 18th edition of the Aesthetic & Anti-Aging Medicine World Congress.
MERZ AESTHETICS® TAPS GWYNETH PALTROW AS THE GLOBAL FACE OF XEOMIN® (incobotulinumtoxinA)
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today a partnership with Oscar and Emmy-award-winning actor, author and entrepreneur, Gwyneth Paltrow, for the launch of the company’s first global campaign for Xeomin® (incobotulinumtoxinA).
Merz Aesthetics Launches New Vision as World's Largest Dedicated Aesthetics Business
Merz Aesthetics is pleased to announce today the launch of the “confidence to be” branding platform following the conclusion of the company’s reorganization into three independently operating businesses.
Merz Aesthetics Appoints Karl Kokrhoun as Chief Financial Officer
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the appointment of Karl Kokrhoun as Chief Financial Officer, effective May 4, 2020.
Merz Aesthetics Appoints Samantha Kerr, Ph.D., as Chief Scientific Officer
Merz Aesthetics, the largest dedicated medical aesthetics business globally, today announced the appointment of Samantha Kerr, Ph.D., as Chief Scientific Officer, effective March 16, 2020.
Merz Forms Fully focused Global Medical Aesthetics Business: Merz Aesthetics
Merz, a global leader in the field of aesthetics and neurotoxins, today announced plans to reorganize into three independently operating businesses: medical aesthetics, therapeutics and consumer care.
Merz Americas CEO Bob Rhatigan Joins Distinguished Life Sciences Leaders as a PharmaVOICE 100 Award Recipient
Today Merz announced Bob Rhatigan, CEO of Merz Americas, has been named one of the top 100 most inspiring and influential life sciences leaders by PharmaVOICE magazine, a premiere health care trade publication.
Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Third Year in a Row
Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Third Year in a Row... Merz Americas CEO Bob Rhatigan named “Top Aesthetics CEO” for the third year in a row.... Key products XEOMIN®(incobotulinumtoxinA) and Ultherapy® recognized with best-in-class awards
Merz to Present Data Across Aesthetics Portfolio at “The Aesthetic Meeting 2019” in New Orleans
Accepted abstracts provide key updates on aesthetics products, including XEOMIN® (incobotulinumtoxinA), ULTHERAPY®, RADIESSE® and CELLFINA®.
Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Second Year in a Row
For the second year in a row, Merz has been recognized as the “Top Aesthetics Company” by Aesthetic Everything® and Bob Rhatigan has been named the “Top Aesthetics CEO.” As part of the annual Aesthetic and Cosmetic Medicine Awards, Merz executives and products were also recognized with 14 additional award wins – 16 total wins overall.